Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis ; volume:25 ; number:1 ; day:19 ; month:6 ; year:2024 ; pages:1-10 ; date:12.2024
BMC immunology ; 25, Heft 1 (19.6.2024), 1-10, 12.2024

Creator: Hamzavi, Seyedeh Sadigheh
Bahrololoom, Rosemina
Saeb, Sepideh
Marandi, Nahid Heydari
Hosseini, Marzieh
hesam abadi, Alimohammad Keshtvarz
Jamalidoust, Marzieh

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12865-024-00628-w

URN: urn:nbn:de:101:1-2409102100499.955103403566

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hamzavi, Seyedeh Sadigheh
Bahrololoom, Rosemina
Saeb, Sepideh
Marandi, Nahid Heydari
Hosseini, Marzieh
hesam abadi, Alimohammad Keshtvarz
Jamalidoust, Marzieh
SpringerLink (Online service)

Other Objects (12)

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Artikel

Coronavirus - COVID-19 - SARS-COV-2

Buchbeitrag

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Artikel

Coronavirus - COVID-19 - SARS-COV-2

Buchbeitrag

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Artikel

Coronavirus - COVID-19 - SARS-COV-2

Buchbeitrag

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

SARS-COV-2 vaccine responses in renal patient populations

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India

Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity

Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Coronavirus - COVID-19 - SARS-COV-2

Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

Related objects

Reset password